Be alert to early symptoms of leukemia and keep children away from threats

Share This Post


In the clinical field of medicine, leukemia is also called blood cancer and belongs to the category of malignant tumors. It is mainly divided into two types: acute leukemia and chronic leukemia. The difference is the speed and degree of onset. Leukemia is deteriorating faster, and it is often difficult to cure once it has leukemia. Adolescents are more frequent people with leukemia, so parents should always pay attention to the child’s physical condition and clearly distinguish the early symptoms of leukemia.

So what are the symptoms of leukemia?

1. Fever persists

Acute leukemia usually occurs among adolescents, the onset is very rapid, and the treatment time of the disease is very short, often only a few months. Therefore, once the child has a fever, he should be vigilant. The cause of fever is mostly an infection. For example, caused by pneumonia, stomatitis, or ear inflammation, it may sometimes be the symptoms of acute leukemia itself, without any other concomitant infection.

2. Abnormal bleeding

Leukemia patients may bleed from all parts of the body, such as the gums, skin, ear, and even the retina. The most common one is nosebleeds. Sometimes women have excessive menstrual periods, or they may be the first sign of leukemia..

3. Anemia

Patients with leukemia may first develop myelodysplastic syndrome and then slowly develop leukemia. The bone marrow is the main part of the body’s hematopoiesis. Therefore, patients may have anemia, weakness, paleness, etc. due to insufficient hematopoiesis. Symptoms such as palpitations, shortness of breath, and swollen lower extremities may also occur. Patients with various types of leukemia are likely to have signs of anemia, and usually the elderly are more prone to anemia.

4. Bone and joint pain

Leukemia patients suffer from bone pain and joint pain due to the infiltration of the bone and periosteum. The pain can be distributed in the limbs; it can also be diffused in the back; or local joint pain may occur. Bone and joint pain is also one of the significant manifestations of leukemia. If sudden joint and bone pain is unexplained, it is likely that you have leukemia.

5. Enlargement of liver, spleen and lymph nodes

Fifty percent of patients with leukemia will have symptoms of hepatospleen and lymphadenopathy, and acute lymphoblastic leukemia has the most obvious lymphadenopathy. The swollen lymph nodes are usually soft or medium-hard, with a smooth surface, no pain when pressed, and no adhesions.

6. Lesions on the skin and mucous membranes

The skin damage of leukemia patients manifests as nodules, lumps, and spots. Mucosal lesions refer to the swelling and ulcers of the oral mucosa, nasal mucosa, and respiratory mucosa. Pay attention to distinguish them from general ulcer diseases.

Leukemia is mainly caused by the increase of red blood cells and platelets in patients, and abnormal bone marrow, mainly affected by environmental factors and genetic factors. Therefore, it is recommended that patients adjust their daily diet to include more blood and nourishing foods, enhance bone health, and help prevent leukemia.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Adagrasib with cetuximab has received accelerated approval by FDA for KRAS G12C-mutated colorectal cancer
Colon cancer

Adagrasib with cetuximab has received accelerated approval by FDA for KRAS G12C-mutated colorectal cancer

The FDA has granted accelerated approval to Adagrasib combined with Cetuximab for treating KRAS G12C-mutated colorectal cancer. This approval is based on promising clinical trial results showing enhanced efficacy of the drug duo. Adagrasib, a KRAS inhibitor, and Cetuximab, an EGFR inhibitor, together target the cancer more effectively, offering new hope for patients with this specific genetic mutation, aiming to improve survival rates and treatment outcomes.

Pembrolizumab with chemotherapy is approved by the USFDA for primary advanced or recurrent endometrial carcinoma
Endometrial cancer

Pembrolizumab with chemotherapy is approved by the USFDA for primary advanced or recurrent endometrial carcinoma

The USFDA has approved Pembrolizumab combined with chemotherapy for treating primary advanced or recurrent endometrial carcinoma. This approval is based on clinical trial data showing significant improvements in patient outcomes. Pembrolizumab, an immune checkpoint inhibitor, works by enhancing the body’s immune response against cancer cells. This combination therapy offers a new and promising treatment option for patients facing this challenging and often aggressive cancer.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy